I am still a bit bemused by the wording of the announcement.
”FDA has informed the company that following additional consideration the available clinical data from its Phase 3 study MSB-GVHD001 appears sufficient to support submission”
Note - not “data”, not “new information”, but “consideration”.
Were the FDA head honchos having a round of golf, and decided amongst themselves that they had been a bit hard on the Aussie battler? Then back to the clubhouse for a scotch or three.
Or perhaps Big Pharma have “advised” the FDA top order that Meso's gonads have been squeezed enough, so give them a win that also allows BP to make a cheap TO?
Don't get me wrong. My wife is very happy to see the reverse in fortunes, and so quick after that dilutive capital raise too!
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-451
-
-
- There are more pages in this discussion • 646 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.11 |
Change
0.055(5.24%) |
Mkt cap ! $1.261B |
Open | High | Low | Value | Volume |
$1.05 | $1.13 | $1.04 | $6.781M | 6.207M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 43856 | $1.11 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.11 | 66000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 52505 | 1.100 |
1 | 4552 | 1.095 |
3 | 60574 | 1.090 |
3 | 31716 | 1.085 |
2 | 14000 | 1.080 |
Price($) | Vol. | No. |
---|---|---|
1.110 | 66000 | 1 |
1.115 | 80808 | 1 |
1.120 | 88882 | 4 |
1.125 | 74996 | 5 |
1.130 | 111884 | 6 |
Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |